NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Change In Working Capital : $-0.07 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is NP Life Sciences Health Industry Group Change In Working Capital?

NP Life Sciences Health Industry Group's change in working capital for the quarter that ended in Dec. 2023 was $0.00 Mil.

NP Life Sciences Health Industry Group's change in working capital for the fiscal year that ended in Dec. 2023 was $-0.07 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

NP Life Sciences Health Industry Group Change In Working Capital Historical Data

The historical data trend for NP Life Sciences Health Industry Group's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NP Life Sciences Health Industry Group Change In Working Capital Chart

NP Life Sciences Health Industry Group Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-0.01

-0.03

0.11

-0.07

NP Life Sciences Health Industry Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															0.10	0.02	-0.08	-0.01	-

NP Life Sciences Health Industry Group Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

NP Life Sciences Health Industry Group Change In Working Capital Related Terms

Thank you for viewing the detailed overview of NP Life Sciences Health Industry Group's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » NP Life Sciences Health Industry Group Inc (OTCPK:NPLS) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

4125 Blackhawk Plaza Circle, Suite 166, Danville, CA, USA, 94506

Website

https://www.gjcc.us

NP Life Sciences Health Industry Group Inc offers international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. Its revenues are comprised of providing promotions and consulting services to its partner who gives international study tour services, commission to be received from partner enrollment services and mental health consulting services.

Executives

Guidong Wang	director, 10 percent owner, officer: Chairman, CEO. Pres, Treas	4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Huaying Zhu	director, officer: Secretary	4125 BLACKHAWK PLAZA CIRCLE, SUITE 168, DANVILLE CA 94506
Jonathan Ginsberg	director	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Sanjun Kuang	director, officer: CEO, President and Treasurer	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Meisang Hu	director, 10 percent owner	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Huawei Li	director, officer: Secretary	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506
Jianhua Wang	10 percent owner	4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE CA 94506

NP Life Sciences Health Industry Group (NP Life Sciences Health Industry Group) Headlines

No Headlines